An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy (Q44371735)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2003
edit
Language Label Description Also known as
English
An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy
scientific article published in April 2003

    Statements

    An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy (English)
    1 April 2003
    141-149

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit